European Healthtech startup funding raised during March 2023.
In March 2023, 58 European Healthtech companies raised a combined €520M across 58 funding rounds, down 43.3% versus March 2022. Switzerland led by capital raised, and Sofinnova Partners was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Noema Pharma | Series B | Mar 2023 | €105M |
| Medwing | Series C | Mar 2023 | €44M |
| Lunaphore Technologies | Series D+ | Mar 2023 | €40M |
| Owkin | Grant |
4 exits.
| Mar 2023 |
| €33M |
| Fire1 | Other | Mar 2023 | €24M |
| Inato | Other | Mar 2023 | €18M |
| Perspectum | Series C | Mar 2023 | €18M |
| Qida | Other | Mar 2023 | €18M |
| Sunrise | Other | Mar 2023 | €17M |
| Iktos | Series A | Mar 2023 | €16M |
| Kiro | Series A | Mar 2023 | €14M |
| SolasCure | Series B | Mar 2023 | €12M |
| Deepc | Other | Mar 2023 | €12M |
| Vitestro | Series A | Mar 2023 | €12M |
| Genialis | Series A | Mar 2023 | €12M |